Manufacturer record
Caremax Formulations: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Caremax Formulations (Himachal Pradesh) were declared Not of Standard Quality between October 2019 and October 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Caremax Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Tablets IP (DECIFEN-50 TABLETS | CLT-14750Mfg 2020-03 · Exp 2023-02 | Disintegration TestDisintegration | RDTL ChandigarhCDSCO lab | Oct 2021 |
| Paracetamol Tablets IP (CAREMOL TABLETS) | CLT-14398Mfg 2019-12 · Exp 2022-11 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Sep 2021 |
| TELMISARTAN TABLETS IP 40 MG | CLT-14747Mfg 2020-03 · Exp 2022-02 | Uniformity of weight & DissolutionDissolution | RDTL ChandigarhCDSCO lab | Apr 2021 |
| Amikacin Sulphate Injection IP (AMIKACARE 500 ) | CLI-6868Mfg 2018-11 · Exp 2020-10 | Particulate MatterParticulate matter | RDTL ChandigarhCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.